PARTNERS
If you have novel, biosimilar or strategically positioned generic assets at Phase 3 or later stages in specialty therapeutic areas and want to expand your global footprint,
We look forward to meeting you!
If you have novel, biosimilar or strategically positioned generic assets at Phase 3 or later stages in specialty therapeutic areas and want to expand your global footprint,
We look forward to meeting you!
Turkey is a large and fast growing market with significant opportunities but also quite complex. TRPharm has a profound knowledge of the Turkish pharmaceutical environment and processes, having a real focus on revenue and business development. Any company looking for building a successful and sustainable business in Turkey, will have excellent support and guidance from TRPharm’s dedicated and extremely competent team.
Antonio Gama Da Silva CEO, Leadiant Biosciences
Our focus as a company has always been putting quality and science first. On this road, we have found an excellent partner in TRPharm. TRPharm has an in depth understanding of their markets and a strong win-win mindset. With top-notch communication and cooperation between us, we have been able to work together to navigate the multitude of regulatory and commercial challenges in the market to provide patients with access to affordable biosimilars.
Dr. Raymond De Vré Global Head of Biologics